Rizzo, C.;                     Amata, S.;                     Pibiri, I.;                     Pace, A.;                     Buscemi, S.;                     Palumbo Piccionello, A.    
        FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022. Int. J. Mol. Sci. 2023, 24, 7728.
    https://doi.org/10.3390/ijms24097728
    AMA Style
    
                                Rizzo C,                                 Amata S,                                 Pibiri I,                                 Pace A,                                 Buscemi S,                                 Palumbo Piccionello A.        
                FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022. International Journal of Molecular Sciences. 2023; 24(9):7728.
        https://doi.org/10.3390/ijms24097728
    
    Chicago/Turabian Style
    
                                Rizzo, Carla,                                 Sara Amata,                                 Ivana Pibiri,                                 Andrea Pace,                                 Silvestre Buscemi,                                 and Antonio Palumbo Piccionello.        
                2023. "FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022" International Journal of Molecular Sciences 24, no. 9: 7728.
        https://doi.org/10.3390/ijms24097728
    
    APA Style
    
                                Rizzo, C.,                                 Amata, S.,                                 Pibiri, I.,                                 Pace, A.,                                 Buscemi, S.,                                 & Palumbo Piccionello, A.        
        
        (2023). FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022. International Journal of Molecular Sciences, 24(9), 7728.
        https://doi.org/10.3390/ijms24097728